Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
IperionX Limited delivers a quarterly update highlighting solid progress in titanium powder production, advanced product manufacturing capabilities, successful prototype developments across multiple sectors, and significant U.S. Government support facilitating expansion and liquidity. The company also completed a positive feasibility study for its …
Cingulate Inc. announced the publication of successful Phase 3 clinical trial results for its ADHD treatment candidate CTx-1301 in the Journal of Child and Adolescent Psychopharmacology. The trial demonstrated significant efficacy and safety in children and adolescents using a novel Precision Timed Release platform, supporting its potential as a on…
VenHub Global, Inc. reports progress in its autonomous retail business following its Nasdaq public debut, highlighting expanded production capacity with a new 25,000 sq. ft. facility, extended flagship store partnership at LAX Metro Transit Center, new deployments in Las Vegas and Florida, and a growing patent portfolio supporting its AI-driven sma…
Disc Medicine released its Q2 2026 financial results and business updates, highlighting progress in its hematologic disease drug pipeline. Key milestones include completion of Phase 3 enrollment and FDA alignment on bitopertin's APOLLO trial in erythropoietic protoporphyria, enrollment completion and upcoming data for DISC-3405 in polycythemia vera…
Cemtrex's subsidiary Vicon Industries has received a purchase order worth approximately $900,000 to provide an end-to-end security platform for a U.S. corrections facility. The order includes a wide range of surveillance hardware and software, reflecting strong demand for reliable, long-term physical security solutions in the corrections sector. Th…
Snail, Inc. (Nasdaq: SNAL) announced it will unveil its internally developed AAA title '9 Yin Sutra: Immortal' during ChinaJoy 2026. The new open-world sandbox cultivation game represents a next-generation genre experience aimed at current gaming market trends. Snail Games will also showcase other titles including PixARK: Terracrypt DLC and the rei…
Ming Shing Group Holdings Limited announced it has signed a non-binding strategic cooperation framework agreement with Meal Though Seasons HK Limited. The partnership aims to explore the application of PMA’s graphene thermal management technology in organic agriculture, including temperature control, anti-freezing, low-temperature drying, and cold-…
PN Smart Energy Limited has successfully acquired the remaining 56% equity interest in Nanjing Cesun Power, making it a wholly-owned subsidiary. This acquisition enhances PN Smart's capabilities in photovoltaic development, EPC, and operations, supporting its strategic transition toward becoming a vertically integrated independent power producer sp…
ARKO Petroleum Corp., a leading wholesale fuel distributor in North America, has scheduled its second quarter 2026 financial results release and conference call for August 6, 2026. The company will share detailed performance figures followed by a Q&A session with management.
Yesway, Inc., a fast-growing U.S. convenience store operator, will release its financial results for Q2 2026 before market open on August 13, 2026, and host a conference call to discuss the results.
Lexicon Pharmaceuticals, a biopharmaceutical company, will report its second quarter 2026 financial results on August 6, 2026 before the market opens. Management will host a conference call and webcast to discuss the results and provide a business update. The company focuses on developing drug candidates in neuropathic pain, hypertrophic cardiomyop…
The Elmet Group Co., a U.S.-based provider of precision-engineered components and advanced high-energy systems, announced it will hold a conference call on August 13, 2026, to discuss its financial results for the second quarter ended June 30, 2026. The company serves multiple sectors including Aerospace, Defense, Industrial, Medical, Semiconductor…
AVAX One Technology Ltd., a digital infrastructure company listed on Nasdaq under ticker AVX, announced its Q2 2026 financial results conference call will be held on August 13, 2026. The company will release its earnings prior to the call and its management will discuss financial and operational performance, followed by a Q&A session.
ARKO Corp., a Fortune 1000 company and one of the largest U.S. convenience store operators, announced it will release its second quarter 2026 financial results on August 7, 2026, followed by a conference call to discuss the results.
InterDigital, Inc. reported strong Q2 2026 financial results with annualized recurring revenue reaching a record $626 million, up 13% year-over-year, driven notably by a new streaming and cloud services licensing agreement with Amazon. Despite a decline in GAAP revenue due to reduced catch-up revenue and higher operating expenses related to IP enfo…
Cabot Corporation disclosed a leadership transition with President and CEO Sean Keohane retiring effective September 30, 2026. Erica McLaughlin, current Executive Vice President and CFO, will succeed him as President and CEO starting October 1, 2026. Keohane will remain as advisor through the end of 2026 to ensure a smooth leadership transition. Th…
Safe Pro Group Inc. successfully completed participation in the U.S. Army's Project Convergence Capstone 6 (PC-C6) exercise, showcasing its AI-powered threat detection and mapping technologies utilizing drone-based imagery. Its NODE-X and OnSight solutions trained soldiers to identify and map explosives and threats on the battlefield, supporting th…
Celcuity Inc. announced that its FDA-approved drug REVTORPYK (gedatolisib) has been included as a preferred Category 1 second-line or subsequent treatment for HR+/HER2- locally advanced or metastatic breast cancer in the NCCN Clinical Practice Guidelines. REVTORPYK demonstrated significant improvements in progression free survival and response rate…
NewGenIVF Group Limited reported a net profit of US$9.9 million for 2025 and expects its total shares outstanding to reach 5.9 million following recent share issuance. The company's 13% stake in K25.ai is now valued at approximately US$26 million after K25.ai's Series A funding round, representing an unrealized gain of US$8.5 million and enhancing …
Full House Resorts announced the release date for its second quarter 2026 financial results as August 6, 2026, along with a conference call and webcast for investors. The company operates multiple gaming facilities across the United States and provided standard forward-looking statement disclaimers.
Lantronix Inc. (Nasdaq: LTRX) has partnered with Swarmer Inc. (Nasdaq: SWMR) to develop a custom compute module optimized for Group 1 Unmanned Aerial Systems (UAS). This collaboration aims to deliver an NDAA-compliant, edge AI compute platform with roughly four times the processing power of existing systems, enhancing autonomous drone capabilities …
Clearmind Medicine Inc. announced positive safety and tolerability data from Part A of its FDA-regulated Phase I/II clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate for Alcohol Use Disorder (AUD). The trial successfully completed dose escalation with no serious adverse events, supporting further clinical development …
Red River Bancshares, Inc. reported its Q2 2026 financial results showing net income of $11.8 million with a slight decrease from the prior quarter but a 15.4% increase year-over-year. The company achieved a 10 basis point improvement in its net interest margin to 3.61% driven by higher loan yields and lower deposit costs. Assets slightly declined …
SAB Biotherapeutics, a clinical-stage biopharmaceutical company focused on autoimmune diseases, will release its Q2 2026 financial results on August 6, 2026, and host a conference call to discuss business updates. The company is advancing its lead drug candidate SAB-142 targeting type 1 diabetes in a Phase 2b trial.
Veru Inc., a NASDAQ-listed late clinical stage biopharmaceutical company, announced its CEO will participate in a fireside chat at the Canaccord Genuity's 46th Annual Growth Investors Conference. The company is advancing its Phase 2b PLATEAU clinical study investigating enobosarm in combination with GLP-1 receptor agonists for improved weight loss …
